What does CUP stand for?

Cancer of Unknown Primary

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Canadian Urologic Oncology Group (Groupe Canadien d'Oncologie Urologique) Creative Use of Libraries Cisco Unified Operations Manager Chronic Unilateral Optic Neuropathy Cambridge University Opera Society Center for Ultrafast Optical Science (University of Michigan) Carlisle United Official Supporters Club (UK) California University of Pennsylvania Cambridge University Press Canadian University Press		Candidatura d'Unitat Popular (Catalan countries) Canterbury University Press (New Zealand) Carcinoma of Unknown Primary Careers Using Physics Carupano, Venezuela - Carupano (Airport Code) Catalog Update Process Cataloguing Upgrade Central Utility Plant (University of Colorado Denver) Centralized Ultrasound Processing China Unionpay (credit card company)

Samples in periodicals archive:

miRview mets is designed to accurately identify the primary tumor site in patients presenting with metastatic cancer, as well as in patients whose tumor has not been identified and consequently has been labeled Cancer of Unknown Primary (CUP).

Prometheus and Rosetta Genomics Announce License and Collaboration ...

3) To our knowledge, there are few reported cases of cancer of unknown primary site that were found to have metastasized to the cutaneous-subcutaneous anterior abdominal wall and no cases presenting as an isolated intramuscular abdominal wall mass.

Metastatic adenocarcinoma of unknown primary site

Studies have shown the accuracy rate for this test to be 87 percent, which is much higher than the 20 percent to 30 percent accuracy rate achieved with traditional methods of cancer of unknown primary classification.

New molecular oncology tests for metastatic and breast cancer improve ...

miRview[TM] mets accurately identifies the primary tumor site in metastatic cancer and Cancer of Unknown Primary (CUP).

Rosetta Genomics Strengthens MicroRNA Intellectual Property Position ...

While this melanoma diagnostic test is still in the early stages, Rosetta Genomics plans to launch three diagnostic products in 2008 that include a test for cancer of unknown primary ("CUP") and two differential diagnostic tests related to lung cancer.

NYU collaborates with Rosetta to develop a microRNA-based diagnostic ...

The following tests will be distributed by Genetic Technologies: * miRview[TM] mets - This test can accurately identify the primary tumor site in patients presenting with metastatic cancer, as well in patients whose tumor has not been identified, and consequently been labeled Cancer of Unknown Primary (CUP).

Rosetta Genomics Names Genetic Technologies Limited Exclusive ...

The following tests will be distributed by AXA Diagnostics: * miRview[TM] mets - This test can accurately identify the primary tumor site in patients presenting with metastatic cancer, as well as in patients whose tumor has not been identified, and consequently been labeled Cancer of Unknown Primary (CUP).

AXA Diagnostics Named Exclusive Distributor for Rosetta Genomics' ...

The following tests will be distributed by SRL: * miRview[TM] mets - This test can accurately identify the primary tumor site in patients presenting with metastatic cancer, as well in patients whose tumor has not been identified, and consequently been labeled Cancer of Unknown Primary (CUP).

Rosetta Genomics and Super Religare Laboratories Limited (SRL) ...